183 related articles for article (PubMed ID: 38675915)
1. Quantitation of Enterovirus A71 Empty and Full Particles by Sedimentation Velocity Analytical Ultracentrifugation.
Yang A; Luo Y; Yang J; Xie T; Wang W; Wan X; Wang K; Pang D; Yang D; Dai H; Wu J; Meng S; Guo J; Wang Z; Shen S
Viruses; 2024 Apr; 16(4):. PubMed ID: 38675915
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Coxsackievirus A5 Vaccine Candidates in an Actively Immunized Mouse Model.
Jin WP; Lu J; Zhang XY; Wu J; Wei ZN; Mai JY; Qian SS; Yu YT; Meng SL; Wang ZJ; Shen S
J Virol; 2021 Feb; 95(6):. PubMed ID: 33408178
[TBL] [Abstract][Full Text] [Related]
3. Immunological and biochemical characterizations of coxsackievirus A6 and A10 viral particles.
Liu CC; Guo MS; Wu SR; Lin HY; Yang YT; Liu WC; Chow YH; Shieh DB; Wang JR; Chong P
Antiviral Res; 2016 May; 129():58-66. PubMed ID: 26899790
[TBL] [Abstract][Full Text] [Related]
4. Enterovirus 71: a whole virion inactivated enterovirus 71 vaccine.
Zhou Y; Li JX; Jin PF; Wang YX; Zhu FC
Expert Rev Vaccines; 2016 Jul; 15(7):803-13. PubMed ID: 27206811
[TBL] [Abstract][Full Text] [Related]
5. EV71 vaccine, a new tool to control outbreaks of hand, foot and mouth disease (HFMD).
Mao QY; Wang Y; Bian L; Xu M; Liang Z
Expert Rev Vaccines; 2016 May; 15(5):599-606. PubMed ID: 26732723
[TBL] [Abstract][Full Text] [Related]
6. An inactivated hand-foot-and-mouth disease vaccine using the enterovirus 71 (C4a) strain isolated from a Korean patient induces a strong immunogenic response in mice.
In HJ; Lim H; Lee JA; Kim HJ; Kim JW; Hyeon JY; Yeo SG; Lee JW; Yoo JS; Choi YK; Lee SW
PLoS One; 2017; 12(5):e0178259. PubMed ID: 28542556
[TBL] [Abstract][Full Text] [Related]
7. Production of EV71 vaccine candidates.
Chong P; Hsieh SY; Liu CC; Chou AH; Chang JY; Wu SC; Liu SJ; Chow YH; Su IJ; Klein M
Hum Vaccin Immunother; 2012 Dec; 8(12):1775-83. PubMed ID: 22992566
[TBL] [Abstract][Full Text] [Related]
8. Recent development of enterovirus A vaccine candidates for the prevention of hand, foot, and mouth disease.
Fang CY; Liu CC
Expert Rev Vaccines; 2018 Sep; 17(9):819-831. PubMed ID: 30095317
[TBL] [Abstract][Full Text] [Related]
9. Enterovirus 71 vaccine: close but still far.
Zhang D; Lu J; Lu J
Int J Infect Dis; 2010 Sep; 14(9):e739-43. PubMed ID: 20400350
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of EV-A71 vaccination in prevention of paediatric hand, foot, and mouth disease associated with EV-A71 virus infection requiring hospitalisation in Henan, China, 2017-18: a test-negative case-control study.
Li Y; Zhou Y; Cheng Y; Wu P; Zhou C; Cui P; Song C; Liang L; Wang F; Qiu Q; Guo C; Zeng M; Long L; Cowling BJ; Yu H
Lancet Child Adolesc Health; 2019 Oct; 3(10):697-704. PubMed ID: 31375313
[TBL] [Abstract][Full Text] [Related]
11. A virus-like particle-based tetravalent vaccine for hand, foot, and mouth disease elicits broad and balanced protective immunity.
Zhang W; Dai W; Zhang C; Zhou Y; Xiong P; Wang S; Ye X; Liu Q; Zhou D; Huang Z
Emerg Microbes Infect; 2018 May; 7(1):94. PubMed ID: 29777102
[TBL] [Abstract][Full Text] [Related]
12. Characterizing Enterovirus 71 and Coxsackievirus A16 virus-like particles production in insect cells.
Somasundaram B; Chang C; Fan YY; Lim PY; Cardosa J; Lua L
Methods; 2016 Feb; 95():38-45. PubMed ID: 26410190
[TBL] [Abstract][Full Text] [Related]
13. A novel inactivated enterovirus 71 vaccine can elicit cross-protective immunity against coxsackievirus A16 in mice.
Yang L; Liu Y; Li S; Zhao H; Lin Q; Yu H; Huang X; Zheng Q; Cheng T; Xia N
Vaccine; 2016 Nov; 34(48):5938-5945. PubMed ID: 27771182
[TBL] [Abstract][Full Text] [Related]
14. Recombinant adeno-vaccine expressing enterovirus 71-like particles against hand, foot, and mouth disease.
Tsou YL; Lin YW; Shao HY; Yu SL; Wu SR; Lin HY; Liu CC; Huang C; Chong P; Chow YH
PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003692. PubMed ID: 25855976
[TBL] [Abstract][Full Text] [Related]
15. Inactivated enterovirus 71 with poly-γ-glutamic acid/Chitosan nano particles (PC NPs) induces high cellular and humoral immune responses in BALB/c mice.
Pathinayake PS; Gayan Chathuranga WA; Lee HC; Chowdhury MYE; Sung MH; Lee JS; Kim CJ
Arch Virol; 2018 Aug; 163(8):2073-2083. PubMed ID: 29619599
[TBL] [Abstract][Full Text] [Related]
16. Structures of Coxsackievirus A16 Capsids with Native Antigenicity: Implications for Particle Expansion, Receptor Binding, and Immunogenicity.
Ren J; Wang X; Zhu L; Hu Z; Gao Q; Yang P; Li X; Wang J; Shen X; Fry EE; Rao Z; Stuart DI
J Virol; 2015 Oct; 89(20):10500-11. PubMed ID: 26269176
[TBL] [Abstract][Full Text] [Related]
17. Review of enterovirus 71 vaccines.
Chong P; Liu CC; Chow YH; Chou AH; Klein M
Clin Infect Dis; 2015 Mar; 60(5):797-803. PubMed ID: 25352588
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of monovalent and bivalent vaccines against lethal Enterovirus 71 and Coxsackievirus A16 infection in newborn mice.
Sun S; Jiang L; Liang Z; Mao Q; Su W; Zhang H; Li X; Jin J; Xu L; Zhao D; Fan P; An D; Yang P; Lu J; Lv X; Sun B; Xu F; Kong W; Jiang C
Hum Vaccin Immunother; 2014; 10(10):2885-95. PubMed ID: 25483672
[TBL] [Abstract][Full Text] [Related]
19. Optimized development of a candidate strain of inactivated EV71 vaccine and analysis of its immunogenicity in rhesus monkeys.
Dong C; Wang J; Liu L; Zhao H; Shi H; Zhang Y; Jiang L; Li Q
Hum Vaccin; 2010 Dec; 6(12):1028-37. PubMed ID: 21150270
[TBL] [Abstract][Full Text] [Related]
20. The compatibility of inactivated-Enterovirus 71 vaccination with Coxsackievirus A16 and Poliovirus immunizations in humans and animals.
Mao Q; Wang Y; Shao J; Ying Z; Gao F; Yao X; Li C; Ye Q; Xu M; Li R; Zhu F; Liang Z
Hum Vaccin Immunother; 2015; 11(11):2723-33. PubMed ID: 25715318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
